Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 2
1985 4
1986 12
1987 5
1988 21
1989 5
1990 5
1991 12
1992 11
1993 23
1994 32
1995 7
1996 14
1997 13
1998 12
1999 11
2000 11
2001 15
2002 9
2003 18
2004 15
2005 15
2006 16
2007 14
2008 23
2009 22
2010 13
2011 16
2012 10
2013 14
2014 18
2015 23
2016 14
2017 19
2018 16
2019 23
2020 27
2021 31
2022 34
2023 28
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

608 results

Results by year

Filters applied: . Clear all
Page 1
Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Manolis A, Kallistratos M, Doumas M. Manolis A, et al. Curr Pharm Des. 2021;27(23):2714-2721. doi: 10.2174/1381612827666210406142933. Curr Pharm Des. 2021. PMID: 33823773 Review.
In heart failure (HF) patients, current European Society of Cardiology (ESC) guidelines recommend the use of three loop diuretics (furosemide, torasemide, bumetanide) in order to not only reduce HF hospitalizations but also improve symptoms and exercise capacity in patient …
In heart failure (HF) patients, current European Society of Cardiology (ESC) guidelines recommend the use of three loop diuretics (furosemid …
Torasemide prolonged release.
Lyseng-Williamson KA. Lyseng-Williamson KA. Drugs. 2009 Jul 9;69(10):1363-72. doi: 10.2165/00003495-200969100-00006. Drugs. 2009. PMID: 19583454 Review.
The antihypertensive efficacy of once-daily torasemide PR 5-10 mg was noninferior to that of once-daily torasemide IR 5-10 mg with regard to the change from baseline in sitting diastolic BP (primary endpoint) in a 12-week, randomized, double-blind trial in patients …
The antihypertensive efficacy of once-daily torasemide PR 5-10 mg was noninferior to that of once-daily torasemide IR 5-10 mg …
[Torasemide].
Escolar M, Quetglas EG, Honorato J. Escolar M, et al. Rev Med Univ Navarra. 1996 Oct-Dec;40(4):45-52. Rev Med Univ Navarra. 1996. PMID: 9499834 Review. Spanish. No abstract available.
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Sherif NA, Morra ME, Thanh LV, Elsayed GG, Elkady AH, Elshafay A, Kien ND, Al-Habbaa A, Minh LHN, Y MN, Nghia TLB, Mohammed AT, Eid PS, Turk T, Hirayama K, Huy NT. Sherif NA, et al. J Eval Clin Pract. 2020 Jun;26(3):842-851. doi: 10.1111/jep.13261. Epub 2019 Aug 21. J Eval Clin Pract. 2020. PMID: 31436024 Review.

AIM: Diuretics are a cornerstone in treatment of heart failure (HF). Torasemide is a loop diuretic with a potential advantage over other diuretics. ...However, oral torasemide has a significant lower hospital stay P < .001 and superior effect in improving ejectio

…
AIM: Diuretics are a cornerstone in treatment of heart failure (HF). Torasemide is a loop diuretic with a potential advantage over ot …
Torasemide in comparison with thiazides in the treatment of hypertension.
Baumgart P. Baumgart P. Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:63-8. doi: 10.1007/BF00877959. Cardiovasc Drugs Ther. 1993. PMID: 8435378 Review.
There are a number of clinically relevant differences between torasemide and the thiazide diuretics in the treatment of hypertension. Only 2.5-5 mg torasemide once daily is sufficient for antihypertensive treatment; these low doses of torasemide exert compara …
There are a number of clinically relevant differences between torasemide and the thiazide diuretics in the treatment of hypertension. …
[Update: prolonged-release torasemide].
Acuña C. Acuña C. Drugs Today (Barc). 2010 Jul;46 Suppl E:1-15. Drugs Today (Barc). 2010. PMID: 20882198 Review. Spanish.
Torasemide reversed myocardial fibrosis and reduced collagen type I synthesis, improving cardiac remodeling in patients with CHF. Torasemide prolonged-release (PR) is a new formulation that, compared with torasemide immediate-release, has a similar systemic e …
Torasemide reversed myocardial fibrosis and reduced collagen type I synthesis, improving cardiac remodeling in patients with CHF. …
Torasemide in advanced renal failure.
Kindler J. Kindler J. Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:75-80. doi: 10.1007/BF00877961. Cardiovasc Drugs Ther. 1993. PMID: 8435381 Review.
The lack of a substantial calciuretic effect of torasemide in chronic renal disease needs further confirmation. Two controlled multicenter clinical trials comparing high oral doses of furosemide and torasemide in patients with end-stage renal disease requiring maint …
The lack of a substantial calciuretic effect of torasemide in chronic renal disease needs further confirmation. Two controlled multic …
Torasemide for the treatment of heart failure.
Ishido H, Senzaki H. Ishido H, et al. Cardiovasc Hematol Disord Drug Targets. 2008 Jun;8(2):127-32. doi: 10.2174/187152908784533685. Cardiovasc Hematol Disord Drug Targets. 2008. PMID: 18537599 Review.
Torasemide also appears to have additional actions beyond the pure diuretic effect, such as anti-aldosterone effect and vasorelaxation effect. ...Thus, torasemide appears to be a promising loop diuretic that contributes to a better management of patients with heart …
Torasemide also appears to have additional actions beyond the pure diuretic effect, such as anti-aldosterone effect and vasorelaxatio …
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ; TRANSFORM-HF Investigators. Mentz RJ, et al. JAMA. 2023 Jan 17;329(3):214-223. doi: 10.1001/jama.2022.23924. JAMA. 2023. PMID: 36648467 Free PMC article. Clinical Trial.
IMPORTANCE: Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential benefit for torsemide. OBJECTIVE: To determine whether torsemide results in decreased mortality compared with furosemide among pa …
IMPORTANCE: Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential ben …
Torasemide. An update of its pharmacological properties and therapeutic efficacy.
Dunn CJ, Fitton A, Brogden RN. Dunn CJ, et al. Drugs. 1995 Jan;49(1):121-42. doi: 10.2165/00003495-199549010-00009. Drugs. 1995. PMID: 7705212 Review.
The pharmacological properties and therapeutic use of the high-ceiling loop diuretic torasemide (torsemide) were previously reviewed in Drugs in 1991, the following being a re-examination of the role of the drug in the light of data that have subsequently become ava …
The pharmacological properties and therapeutic use of the high-ceiling loop diuretic torasemide (torsemide) were previously re …
608 results

Searches related to "torasemide"